Neurent Medical
Private Company
Total funding raised: $70M
Overview
Neurent Medical is a commercial-stage medical device company focused on innovating treatments for chronic rhinitis. Its core technology, the NEUROMARK System, is a clinically proven, minimally invasive procedure that uses low-power energy to disrupt the posterior nasal nerves, aiming for lasting symptom relief with minimal downtime. The company is targeting the large and underserved patient population suffering from chronic rhinitis, positioning itself as a provider of a targeted, in-office solution for ENT specialists.
Technology Platform
Minimally invasive neuromodulation platform using low-power, temperature-controlled radiofrequency energy and real-time apposition confirmation to target overactive nerves in chronic inflammatory conditions.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
NEUROMARK competes in the minimally invasive rhinitis treatment market against other office-based devices using technologies like cryotherapy (e.g., ClariFix) and other radiofrequency systems. It also competes indirectly with continued pharmacological management and more invasive surgical procedures. Differentiation is based on its targeted posterior nasal nerve approach, apposition confirmation technology, and clinical data.